Islet-1 is a dual regulator of fibrogenic epithelial-to-mesenchymal transition in epicardial mesothelial cells

Experimental Cell Research

Volumn 319, Issue 4, 2013, Pages 424-435

  Brønnum, Hasse ^a,b   Andersen, Ditte C ^a,b   Schneider, Mikael ^a,b   Yaël Nossent, Anne ^a,b   Nielsen, Solveig B ^a,b   Sheikh, Søren P ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Epicardium; Epithelial to mesenchymal transition; Fibrosis; Islet 1; MicroRNA 31

Indexed keywords

BETA CATENIN; MICRORNA 31; MYOCARDIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ISLET 1; UNCLASSIFIED DRUG; INSULIN GENE ENHANCER BINDING PROTEIN ISL 1; INSULIN GENE ENHANCER BINDING PROTEIN ISL-1; LIM HOMEODOMAIN PROTEIN; MICRORNA; MIRN31 MICRORNA, RAT; NUCLEAR PROTEIN; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; CELL ACTIVITY; CELL PROLIFERATION; EPICARDIUM; EPITHELIAL MESENCHYMAL TRANSITION; FIBROGENESIS; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE; MESOTHELIUM CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA BINDING; TRANSCRIPTION REGULATION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM; EPITHELIUM CELL; FIBROBLAST; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; METABOLISM; PATHOLOGY; PERICARDIUM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; CELLS, CULTURED; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; EPITHELIUM; FIBROBLASTS; FIBROSIS; GENE EXPRESSION REGULATION; LIM-HOMEODOMAIN PROTEINS; MICRORNAS; MYOCARDIUM; NUCLEAR PROTEINS; PERICARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

MLCS; MLOWN;

EID: 84875526984     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.12.019     Document Type: Article

References (51)

1. Gittenberger-de Groot A.C., Vrancken Peeters M.P., Mentink M.M., Gourdie R.G., Poelmann R.E. Epicardium-derived cells contribute a novel population to the myocardial wall and the atrioventricular cushions. Circ. Res. 1998, 82:1043-1052.
2. Merki E., Zamora M., Raya A., Kawakami Y., Wang J., Zhang X., Burch J., Kubalak S.W., Kaliman P., Belmonte J.C., Chien K.R., Ruiz-Lozano P. Epicardial retinoid X receptor alpha is required for myocardial growth and coronary artery formation. Proc. Natl. Acad. Sci. USA 2005, 102:18455-18460.
3. Zhou B., Ma Q., Rajagopal S., Wu S.M., Domian I., Rivera-Feliciano J., Jiang D., von Gise A., Ikeda S., Chien K.R., Pu W.T. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 2008, 454:109-113.
4. Manner J. Does the subepicardial mesenchyme contribute myocardioblasts to the myocardium of the chick embryo heart? A quail-chick chimera study tracing the fate of the epicardial primordium. Anat. Rec. 1999, 255:212-226.
5. Di Meglio F., Castaldo C., Nurzynska D., Romano V., Miraglia R., Bancone C., Langella G., Vosa C., Montagnani S. Epithelial-mesenchymal transition of epicardial mesothelium is a source of cardiac CD117-positive stem cells in adult human heart. J. Mol. Cell. Cardiol. 2010, 49:719-727.
6. Russell J.L., Goetsch S.C., Gaiano N.R., Hill J.A., Olson E.N., Schneider J.W. A dynamic notch injury response activates epicardium and contributes to fibrosis repair. Circ. Res. 2011, 108:51-59.
7. Smart N., Risebro C.A., Melville A.A., Moses K., Schwartz R.J., Chien K.R., Riley P.R. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature 2007, 445:177-182.
8. van Tuyn J., Atsma D.E., Winter E.M., van der Velde-van Dijke I., Pijnappels D.A., Bax N.A., Knaan-Shanzer S., Gittenberger-de Groot A.C., Poelmann R.E., van der Laarse A., van der Wall E.E., Schalij M.J., de Vries A.A. Epicardial cells of human adults can undergo an epithelial-to-mesenchymal transition and obtain characteristics of smooth muscle cells in vitro. Stem Cells 2007, 25:271-278.
9. Porter K.E., Turner N.A. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Ther. 2009, 123:255-278.
10. Xu J., Lamouille S., Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009, 19:156-172.
11. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:1420-1428.
12. Laugwitz K.L., Moretti A., Caron L., Nakano A., Chien K.R. Islet1 cardiovascular progenitors: a single source for heart lineages?. Development 2008, 135:193-205.
13. Kwon C., Qian L., Cheng P., Nigam V., Arnold J., Srivastava D. A regulatory pathway involving Notch1/beta-catenin/Isl1 determines cardiac progenitor cell fate. Nat. Cell. Biol. 2009, 11:951-957.
14. Long X., Bell R.D., Gerthoffer W.T., Zlokovic B.V., Miano J.M. Myocardin is sufficient for a smooth muscle-like contractile phenotype. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1505-1510.
15. Morita T., Mayanagi T., Sobue K. Dual roles of myocardin-related transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling. J. Cell. Biol. 2007, 179:1027-1042.
16. Qiu P., Ritchie R.P., Fu Z., Cao D., Cumming J., Miano J.M., Wang D.Z., Li H.J., Li L. Myocardin enhances Smad3-mediated transforming growth factor-beta1 signaling in a CArG box-independent manner: Smad-binding element is an important cis element for SM22alpha transcription in vivo. Circ. Res. 2005, 97:983-991.
17. Masszi A., Speight P., Charbonney E., Lodyga M., Nakano H., Szaszi K., Kapus A. Fate-determining mechanisms in epithelial-myofibroblast transition: major inhibitory role for Smad3. J. Cell. Biol. 2010, 188:383-399.
18. Small E.M., Thatcher J.E., Sutherland L.B., Kinoshita H., Gerard R.D., Richardson J.A., Dimaio J.M., Sadek H., Kuwahara K., Olson E.N. Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ. Res. 2010, 107:294-304.
19. Jeppesen P.L., Christensen G.L., Schneider M., Nossent A.Y., Jensen H.B., Andersen D.C., Eskildsen T., Gammeltoft S., Hansen J.L., Sheikh S.P. Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes. Br. J. Pharmacol. 2011, 164:394-404.
20. Andersen D.C., Andersen P., Schneider M., Jensen H.B., Sheikh S.P. Murine cardiospheres are not a source of stem cells with cardiomyogenic potential. Stem Cells 2009, 27:1571-1581.
21. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, (3 (). RESEARCH0034.
22. Hellemans J., Mortier G., De Paepe A., Speleman F., Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007, 8:R19.
23. Rehmsmeier M., Steffen P., Hochsmann M., Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA 2004, 10:1507-1517.
24. H. Brønnum, D.C. Andersen, M. Schneider, M.B. Sandberg, S.B. Nielsen, R. Kalluri, S.P. Sheikh, miR-21 promotes fibrogenic epithelial-to-mesenchymal transition of epicardial mesothelial cells involving programmed cell death 4 and sprouty-1 targeting, PLoS ONE, unpublished results.
25. Savagner P., Yamada K.M., Thiery J.P. The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J. Cell. Biol. 1997, 137:1403-1419.
26. Hajra K.M., Chen D.Y., Fearon E.R. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 2002, 62:1613-1618.
27. Peinado H., Portillo F., Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int. J. Dev. Biol. 2004, 48:365-375.
28. Bu L., Jiang X., Martin-Puig S., Caron L., Zhu S., Shao Y., Roberts D.J., Huang P.L., Domian I.J., Chien K.R. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 2009, 460:113-117.
29. Roy S., Khanna S., Hussain S.R., Biswas S., Azad A., Rink C., Gnyawali S., Shilo S., Nuovo G.J., Sen C.K. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc. Res. 2009, 82:21-29.
30. Thum T., Gross C., Fiedler J., Fischer T., Kissler S., Bussen M., Galuppo P., Just S., Rottbauer W., Frantz S., Castoldi M., Soutschek J., Koteliansky V., Rosenwald A., Basson M.A., Licht J.D., Pena J.T., Rouhanifard S.H., Muckenthaler M.U., Tuschl T., Martin G.R., Bauersachs J., Engelhardt S. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008, 456:980-984.
31. van Rooij E., Sutherland L.B., Thatcher J.E., DiMaio J.M., Naseem R.H., Marshall W.S., Hill J.A., Olson E.N. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. USA 2008, 105:13027-13032.
32. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
33. Cottonham C.L., Kaneko S., Xu L. miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells. J. Biol. Chem. 2010, 285:35293-35302.
34. Aprelikova O., Yu X., Palla J., Wei B.R., John S., Yi M., Stephens R., Simpson R.M., Risinger J.I., Jazaeri A., Niederhuber J. The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. Cell Cycle 2010, 9.
35. Tsai Y.H., Wu M.F., Wu Y.H., Chang S.J., Lin S.F., Sharp T.V., Wang H.W. The M type K15 protein of Kaposi's sarcoma-associated herpesvirus regulates microRNA expression via its SH2-binding motif to induce cell migration and invasion. J. Virol. 2009, 83:622-632.
36. Olaru A.V., Selaru F.M., Mori Y., Vazquez C., David S., Paun B., Cheng Y., Jin Z., Yang J., Agarwal R., Abraham J.M., Dassopoulos T., Harris M., Bayless T.M., Kwon J., Harpaz N., Livak F., Meltzer S.J. Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation. Inflamm. Bowel Dis. 2011, 17:221-231.
37. Liu X., Sempere L.F., Ouyang H., Memoli V.A., Andrew A.S., Luo Y., Demidenko E., Korc M., Shi W., Preis M., Dragnev K.H., Li H., Direnzo J., Bak M., Freemantle S.J., Kauppinen S., Dmitrovsky E. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J. Clin. Invest. 2010, 120:1298-1309.
38. Valastyan S., Reinhardt F., Benaich N., Calogrias D., Szasz A.M., Wang Z.C., Brock J.E., Richardson A.L., Weinberg R.A. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009, 137:1032-1046.
39. Ivanov S.V., Goparaju C.M., Lopez P., Zavadil J., Toren-Haritan G., Rosenwald S., Hoshen M., Chajut A., Cohen D., Pass H.I. Pro-tumorigenic effects of miR-31 loss in mesothelioma. J. Biol. Chem. 2010, 285:22809-22817.
40. Fridman E., Dotan Z., Barshack I., David M.B., Dov A., Tabak S., Zion O., Benjamin S., Benjamin H., Kuker H., Avivi C., Rosenblatt K., Polak-Charcon S., Ramon J., Rosenfeld N., Spector Y. Accurate molecular classification of renal tumors using microRNA expression. J. Mol. Diagn. 2010, 12:687-696.
41. Pedrioli D.M., Karpanen T., Dabouras V., Jurisic G., van de Hoek G., Shin J.W., Marino D., Kalin R.E., Leidel S., Cinelli P., Schulte-Merker S., Brandli A.W., Detmar M. miR-31 functions as a negative regulator of lymphatic vascular lineage-specific differentiation in vitro and vascular development in vivo. Mol. Cell. Biol. 2010, 30:3620-3634.
42. Slaby O., Svoboda M., Fabian P., Smerdova T., Knoflickova D., Bednarikova M., Nenutil R., Vyzula R. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 2007, 72:397-402.
43. Hua D., Ding D., Han X., Zhang W., Zhao N., Foltz G., Lan Q., Huang Q., Lin B. Human miR-31 targets radixin and inhibits migration and invasion of. Oncol. Rep. 2012, 27:700-706.
44. Nelson W.J., Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004, 303:1483-1487.
45. Liu X., Cheng Y., Chen X., Yang J., Xu L., Zhang C. MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2. J. Biol. Chem. 2011, 286:42371-42380.
46. Heldin C.H., Landstrom M., Moustakas A. Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr. Opin. Cell Biol. 2009, 21:166-176.
47. Willis B.C., Borok Z. TGF-beta-induced E.M.T.: mechanisms and implications for fibrotic lung disease. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 293:L525-534.
48. Lin L., Cui L., Zhou W., Dufort D., Zhang X., Cai C.L., Bu L., Yang L., Martin J., Kemler R., Rosenfeld M.G., Chen J., Evans S.M. Beta-catenin directly regulates Islet1 expression in cardiovascular progenitors and is required for multiple aspects of cardiogenesis. Proc. Natl. Acad. Sci. USA 2007, 104:9313-9318.
49. Qyang Y., Martin-Puig S., Chiravuri M., Chen S., Xu H., Bu L., Jiang X., Lin L., Granger A., Moretti A., Caron L., Wu X., Clarke J., Taketo M.M., Laugwitz K.L., Moon R.T., Gruber P., Evans S.M., Ding S., Chien K.R. The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway. Cell Stem Cell 2007, 1:165-179.
50. Liebner S., Cattelino A., Gallini R., Rudini N., Iurlaro M., Piccolo S., Dejana E. Beta-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J. Cell. Biol. 2004, 166:359-367.
51. Zavadil J., Cermak L., Soto-Nieves N., Bottinger E.P. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 2004, 23:1155-1165.